by The adoption of the FDA-approved Alzheimer’s drug, Leqimbi, has slowed down in the U.S. as more experts grow hesitant about the drugs cost, risks and efficacy.The adoption of the FDA-approved Alzheimer’s drug, Leqimbi, has slowed down in the U.S. as more experts grow hesitant about the drugs cost, risks and efficacy.Read Mored3cd916f-7ec8-506a-9c02-aad7f8ff6baf, fox-news/health/nervous-system-health/alzheimers, fox-news/topic/reuters, fox-news/health/nervous-system-health, fnc, fox-news/health, article, ReutersFOX News : Health
